Morning Overview on MSN
FDA approves J&J’s once-daily Icotyde pill for plaque psoriasis
Johnson & Johnson said the FDA approved Icotyde (icotrokinra), a once-daily oral treatment for adults with moderate to severe plaque psoriasis. In a March 18, 2026, announcement, the company described ...
David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...
NeuroRPM, a digital health company focused on Parkinson’s disease monitoring, today announced that its FDA-cleared wearable ...
After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can be only one big winner—if there is a winner at all.
A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered ...
A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered hypertension and prevented ...
A data engineer from Sydney used AI to design what may be the world's first personalized mRNA cancer vaccine for a dog.
The new program is supposed to save taxpayer dollars. Doctors and patients in Washington say that it's disrupting and ...
Medical Device Network on MSN
Sacral neuromodulation: broadening Boston Scientific’s European urology portfolio
Boston Scientific added SNM to its urology portfolio following its 2024 acquisition of Axonics.
As measles cases rise across the United States, clinical leaders must ensure their organizations have the clinical protocols, workforce training, and infection-control infrastructure needed to rapidly ...
This week, Bobbi Conner talks with MUSC's Dr. Andrea Abbott about right-sizing, or tailoring breast cancer treatment to the individual patient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results